In 2018, the market size of human insulin and its analogues in China was estimated to be roughly 20 billion yuan and was expected to continue to grow with an annual compound rate of 4.4 percent until 2030. Insulin therapy is the main treatment among people with type 1 diabetes in which the pancreas no longer produces the hormone (insulin) to regulate the blood sugar level of the body. Some people with type 2 diabetes or gestational diabetes need to take insulin if other medicines can not keep blood glucose levels within the desired range.
…. more: Statista.com (Quelle/Source)